MGH TIP

MGH Therapeutic Intralesional Program: a multi-disciplinary team bringing therapy directly to the tumor microenvironment

[Omid Hamid MD @OmidHamidMD]

Congrats to @Immunocore for @NEJM publication Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma. Proud to be part of this program and its success for our patients
#clinicaltrials @angelesclinic
https://t.co/jqg525hZwk

[richard white @whitefishlab]

How do cells cooperate in cancer? In our new @Dev_Cell paper, we use #zebrafish to show that different types of #melanoma cells stick together to make metastasis more efficient. Led by @TriIMDPhD student @nrcampbell3 in close collaboration with Joao Xavier's lab @sloan_kettering

[Omid Hamid MD @OmidHamidMD]

Congrats @jasonlukemd Phase 3 KEYNOTE-716
KEYTRUDA, @Merck anti-PD-1, met primary endpoint
(RFS) adjuvant high-risk stage II
melanoma vs placebo. Proud to have contributed @angelesclinic @CSCancerCare @UPMCHillmanCC #melanoma

[MGH TIP @MghTip]

Awesome work! Congrats.

[MarineLab @lab_marine]

Thrilled to share our latest piece: Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma https://t.co/anl13gJIhV
Thanks to all outstanding lab members & collaborators @theLundLab @OBechter @LambrechtsDlab @LeucciLRCB (among others)

[Janice Mehnert, MD @JaniceM10]

Love this.

[David Liu @dliu_ccb]

Congratulations @alexshoushtari , @nikolausschultz, @DrBetofMDPhD and co-authors on this thoughtfully conducted deep dive into melanoma subtypes!

[Genevieve Boland, MD, PhD @gmboland]

Check out our work in @ScienceTM demonstrating epitope spread to melanocyte-lineage antigens improves #immune checkpoint blockade responses. It's not just about #neoantigens anymore! @MGH_RI @MGHSurgery @MGHCancerCenter @ASCO https://t.co/s3Yzw17IBn

[Allison Betof, MD, PhD, FASCO @DrBetofMDPhD]

So thankful to @businessinsider for allowing me to describe the joy of vaccine clinic. “The opportunity to really be part of the solution and be on the frontline, not only caring for these patients, but now fixing the problem...this is why you go to med school." @sloan_kettering

[Stephanie Graff, MD, FACP, FASCO @DrSGraff]

As a woman. As a breast oncologist. This dropped my jaw to the floor. This brought tears to my eyes.

WOMEN ACCOUNTED FOR ALL THE JOB LOSSES. Let it sink in.

140,000 examples of the US coming up short on #genderequity.

@tmprowell @JulieSilverMD @choo_ek @reshmajagsi

[MGH TIP @MghTip]

@MHendr1cks My brain had trouble interpreting this one. Modern art.

[Olink Proteomics @OlinkProteomics]

Great article featuring Dr @gmboland available at @SelectScience , where she talks about the importance of #proteomics in her work on malignant melanoma, particularly in the context of #immunotherapy. See the full article: https://t.co/odZcsvTt3J

[Professor De Silva @AshaniTW]

So proud of our student Katherine! We have worried together and celebrated together, and worried together all over again through this crazy year. DACA kids have spent their whole life here, and deserve a path to legalization.

[ACP @ACPIMPhysicians]

@steventwilliams ACP: Falsely Accusing Physicians of Overcounting #COVID19 Deaths for Financial Gain is Reprehensible.

Read ACP's Statement https://t.co/Te6rR2ijyC.

[Mark Lewis, MD, FASCO @marklewismd]

Man, physician satisfaction scores in the 1800s must have been through the roof

[Daniel Peeper @d_peeper]

Check out Julia’s latest paper in Nature Communications on the identification of a pre-existing T cell-resistant melanoma subpopulation that manifests even prior to treatment https://t.co/RMB3SOe0ay

[MassGeneral News @MassGeneralNews]

Today we are thrilled to unveil "We Can Do It Together!", a painting by renowned artist @reonegro whose work is well known to fans of the Grateful Dead. This most recent piece is a tribute to #MGH staff who cared for patients during #COVID19 https://t.co/aPBpgY9LTN

[Anna Obenauf @obenaufa]

We are so excited to present our functional #lineagetracing tool, CaTCH, developed in the @obenaufa lab @IMPvienna published @naturebiotech. Have you ever wondered if a phenotype is pre-existing in a cell or whether it is acquired during selection? Then👇might be your tool!1/14

[T. Salewa Oseni, MD @SOSENI1]

#ASEJC Very true. Your mentors don't have to look like you. I am amazed at how unsettling difference is to people. Difference should not be barrier as long as we are willing to learn.

[Winta T. Mehtsun @wmehtsun]

@Surg_Education We underestimate that academic sponsorship is often a consequence of natural alignment - people mentor those who have experiences similar to their own . I think a key aspect of diversity recruitment in academic surgery is sponshorip of people who's stories are different